Hosted on MSN14h
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for the Rest of 2024
(See BOOT stock forecast) Next on the list is Summit Therapeutics, a clinical-stage biopharma company that has brought a ...
The Globe and Mail19h
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, ...
Mena FN22h
Ultragenyx Presents Positive Update On GTX-102 Angelman Syndrome Program At FAST’S 17Th Annual Global Science Summit
that will be presented at the 2024 Foundation for Angelman Syndrome Therapeutics (FAST) Global Science Summit in Orlando, Florida. “Cognition is the building block for the development and ...
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
Goldman Sachs has upgraded BioNTech SE (NASDAQ:BNTX), citing the company’s BNT327, an immuno-oncology asset in clinical ...
Pakistan Today17h
Zahid Khan, former ANP senator, joins PML-N
He also highlighted the success of the Shanghai Cooperation Organization (SCO) summit in Islamabad as a boost to Pakistan’s ...
The Taipei Times17h
Taiwan News
CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...